News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Plexus Ventures Assists Sylphar with Vendis Capital Investment, Enabling Concordia Fund Exit
Philadelphia, Pennsylvania - Plexus Ventures is pleased to announce it assisted the successful completion of a transaction in which Vendis Capital, a European private equity fund specialized in the consumer brands sector, invested in Sylphar, a fast-growing, Belgian...
Fujifilm Kyowa Kirin Biologics Announces EMA Acceptance to Review Biosimilar FKB327
Philadelphia, PA – Plexus Ventures is pleased to announce that its client, Fujifilm Kyowa Kirin Biologics (FKB), has confirmed that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application for FKB327 (adalimumab biosimilar)....
Events
BIO International Convention - Boston
June 16 – 19, 2025
Click to Schedule a Meeting
CHPI - Frankfurt
October 28 – 30, 2025
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.